Syros Pharmaceuticals Inc (SYRS)
5.37
-0.01
(-0.19%)
USD |
NASDAQ |
Apr 30, 16:00
5.38
+0.01
(+0.19%)
After-Hours: 20:00
Syros Pharmaceuticals Cash from Operations (TTM): -109.71M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -109.71M |
| September 30, 2023 | -122.23M |
| June 30, 2023 | -126.16M |
| March 31, 2023 | -129.95M |
| December 31, 2022 | -123.06M |
| September 30, 2022 | -114.95M |
| June 30, 2022 | -107.29M |
| March 31, 2022 | -107.57M |
| December 31, 2021 | -99.54M |
| September 30, 2021 | -106.50M |
| June 30, 2021 | -93.62M |
| March 31, 2021 | -79.60M |
| December 31, 2020 | -57.36M |
| September 30, 2020 | -38.04M |
| June 30, 2020 | -34.01M |
| March 31, 2020 | -39.68M |
| December 31, 2019 | -60.25M |
| Date | Value |
|---|---|
| September 30, 2019 | -63.46M |
| June 30, 2019 | -62.26M |
| March 31, 2019 | -58.24M |
| December 31, 2018 | -40.32M |
| September 30, 2018 | -37.07M |
| June 30, 2018 | -36.58M |
| March 31, 2018 | -34.31M |
| December 31, 2017 | -44.73M |
| September 30, 2017 | -43.76M |
| June 30, 2017 | -43.40M |
| March 31, 2017 | -42.74M |
| December 31, 2016 | -40.54M |
| September 30, 2016 | -39.14M |
| June 30, 2016 | -35.43M |
| March 31, 2016 | -30.38M |
| December 31, 2015 | -23.03M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-129.95M
Minimum
Mar 2023
-34.01M
Maximum
Jun 2020
-88.17M
Average
-99.54M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
| PDS Biotechnology Corp | -33.64M |
| PAVmed Inc | -52.04M |
| Moderna Inc | -3.118B |
| Altimmune Inc | -75.81M |
| iBio Inc | -18.89M |